Literature DB >> 18372333

The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.

Jocelyn Hewitt1, Xiaghuai Lu, Linda Gilbert, Mark S Nanes.   

Abstract

Transcription factors regulate tissue-specific differentiation of pluripotent mesenchyme to osteoblast (OB), myoblast (MB), and other lineages. Osterix (Osx) is an essential transcription factor for bone development because knockout results in lack of a mineralized skeleton. The proximal Osx promoter contains numerous binding sequences for MyoD and 14 repeats of a binding sequence for Myf5. These basic helix-loop-helix (bHLH) transcription factors have a critical role in MB differentiation and muscle development. We tested the hypothesis that bHLH transcription factors also support OB differentiation through regulation of Osx. Transfection of a MyoD expression vector into two primitive mesenchymal cell lines, C3H/10T1/2 and C2C12, stimulated a 1.2-kb Osx promoter-luciferase reporter 70-fold. Myf5 stimulated the Osx promoter 6-fold. Deletion analysis of the promoter revealed that one of three proximal bHLH sites is essential for MyoD activity. The Myf5 repeat conferred 60% of Myf5 activity with additional upstream sequence required for full activity. MyoD bound the active bHLH sequence and its 3'-flanking region, as shown by EMSA and chromatin immunoprecipitation assays. Real-time PCR revealed that primitive C2C12 and C3H/10T1/2 cells, pre-osteoblastic MC3T3 cells, and undifferentiated primary marrow stromal cells express the muscle transcription factors. C2C12 cells, which differentiate to MB spontaneously and form myotubules, were treated with bone morphogenetic protein 2 (BMP-2) to induce OB differentiation. BMP-2 stimulated expression of Osx and the differentiation marker alkaline phosphatase and blocked myotubule development. BMP-2 suppressed the muscle transcription factor myogenin, but expression of MyoD and Myf5 persisted. Silencing of MyoD inhibited BMP-2 stimulation of Osx and blocked the later appearance of bone alkaline phosphatase. MyoD support of Osx transcription contributes to early OB differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372333     DOI: 10.1210/en.2007-1556

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Bivariate genome-wide linkage analysis of femoral bone traits and leg lean mass: Framingham study.

Authors:  David Karasik; Yanhua Zhou; L Adrienne Cupples; Marian T Hannan; Douglas P Kiel; Serkalem Demissie
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

2.  Retinoic acid maintains human skeletal muscle progenitor cells in an immature state.

Authors:  Marina El Haddad; Cécile Notarnicola; Brendan Evano; Nour El Khatib; Marine Blaquière; Anne Bonnieu; Shahragim Tajbakhsh; Gérald Hugon; Barbara Vernus; Jacques Mercier; Gilles Carnac
Journal:  Cell Mol Life Sci       Date:  2016-12-26       Impact factor: 9.261

3.  The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.

Authors:  Ophélie Philipot; Véronique Joliot; Ouardia Ait-Mohamed; Céline Pellentz; Philippe Robin; Lauriane Fritsch; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

4.  Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a.

Authors:  Renjing Liu; Samantha L Ginn; Monkol Lek; Kathryn N North; Ian E Alexander; David G Little; Aaron Schindeler
Journal:  BMC Musculoskelet Disord       Date:  2009-05-15       Impact factor: 2.362

5.  Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression.

Authors:  Shuang Qu; Jiahui Wu; Qianyi Bao; Bing Yao; Rui Duan; Xiang Chen; Lingyun Li; Hongyan Yuan; Yucui Jin; Changyan Ma
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.